Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
(Total Views: 443)
Posted On: 01/12/2021 4:12:35 PM
Post#
of 149219
Posted By:
mtruong34
Re:
JLang
#72424
I can agree in terms of dosing, RO would be in the domain of P4. As an efficacy predictor, RO would have been great to have in P3.
CYDY Message Board
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
(0)
(0)
Newer
Older
Scroll down for more posts ▼